FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
AlphaTON Capital Corp. Stock AnalysisComprehensive stock analysis for AlphaTON Capital Corp. (ATON) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisATON
ATON
AlphaTON Capital Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ATON
Home🔹Stocks🔹AlphaTON Capital Corp.

AlphaTON Capital Corp.

🇺🇸ATON•NASDAQ

AlphaTON Capital Corp.

🇺🇸ATON•NASDAQ
Market cap
$666.63K
Sentiment

Your view on ATON

Mkt Cap
$666.63K
Sentiment
Your view
ATON
AlphaTON Capital Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ATON
Company Overview

Overview

What the company does, where it operates, and who runs it.

About AlphaTON Capital Corp.

Industry
Asset Management
Sector
Financial Services
CEO
Brittany Kaiser
Headquarters
US
Industry
Asset Management
Sector
Financial Services
CEO
Brittany Kaiser
Headquarters
US
Description

AlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON).

AlphaTON intends to invest significantly in TON tokens, targeting a Long-Term TON treasury of approximately US $100 million.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for AlphaTON Capital Corp., and the rating behind it. ATON last traded at $0.29; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for AlphaTON Capital Corp.. Starting points for AlphaTON Capital Corp.: EPS -$7.10, beta 0.49 — an Asset Management name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for AlphaTON Capital Corp.. AlphaTON Capital Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for AlphaTON Capital Corp.. Trailing twelve-month EPS for AlphaTON Capital Corp. stands at -$7.10. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for AlphaTON Capital Corp.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

AlphaTON Capital Corp. valued side by side against its closest peers. AlphaTON Capital Corp. is measured against Asset Management peers within the Financial Services sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold AlphaTON Capital Corp., and how their positions are changing. At a $666,633 market value, institutional positions materially move AlphaTON Capital Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by AlphaTON Capital Corp. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming AlphaTON Capital Corp.. AlphaTON Capital Corp. is a $666,633 Financial Services company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming AlphaTON Capital Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for AlphaTON Capital Corp.. Coverage tracks AlphaTON Capital Corp. within Asset Management (Financial Services). Press releases and market coverage, newest first.

Peer companies

  • BDRX — Biodexa Pharmaceuticals Plc
  • BHVN — Biohaven Ltd.
  • IMNM — Immunome, Inc.
  • INBX — Inhibrx Biosciences, Inc.
  • KTTA — Pasithea Therapeutics Corp.
  • SER — Serina Therapeutics, Inc.
  • SKYA — SkyAI, Inc.
  • TNON — Tenon Medical, Inc.

More Asset Management companies

  • FPCRX — Future Path 529 JPMorgan BetaBuilders MSCI US REIT ETF Portfolio Z
  • FRMO — FRMO Corporation
  • FRRPF — Fiera Capital Corporation
  • FRTD — Fortitude Group, Inc.
  • FSK — FS KKR Capital Corp.
  • FSZ.TO — Fiera Capital Corporation
  • GAIN — Gladstone Investment Corporation
  • GAING — Gladstone Investment Corporation 7.125% Notes due 2031
  • GAINI — Gladstone Investment Corporation
  • GAINZ — Gladstone Investment Corporation 4.875% Notes due 2028
  • GAMG — Global Asset Management Group I
  • GAMI — GAMCO Investors, Inc.

News

Latest Market News